These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions. Stamnaes J; Fleckenstein B; Sollid LM Biochim Biophys Acta; 2008 Nov; 1784(11):1804-11. PubMed ID: 18793760 [TBL] [Abstract][Full Text] [Related]
7. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease. Dørum S; Qiao SW; Sollid LM; Fleckenstein B J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248 [TBL] [Abstract][Full Text] [Related]
8. Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction. Diós Á; Elek R; Szabó I; Horváth S; Gyimesi J; Király R; Werkstetter K; Koletzko S; Fésüs L; Korponay-Szabó IR Amino Acids; 2021 Jul; 53(7):1051-1063. PubMed ID: 34059947 [TBL] [Abstract][Full Text] [Related]
9. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852 [TBL] [Abstract][Full Text] [Related]
10. A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects. Simon-Vecsei Z; Király R; Bagossi P; Tóth B; Dahlbom I; Caja S; Csosz É; Lindfors K; Sblattero D; Nemes É; Mäki M; Fésüs L; Korponay-Szabó IR Proc Natl Acad Sci U S A; 2012 Jan; 109(2):431-6. PubMed ID: 22198767 [TBL] [Abstract][Full Text] [Related]
11. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize. Korponay-Szabó IR; Vecsei Z; Király R; Dahlbom I; Chirdo F; Nemes E; Fésüs L; Mäki M J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):253-61. PubMed ID: 18376241 [TBL] [Abstract][Full Text] [Related]
12. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease. Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165 [TBL] [Abstract][Full Text] [Related]
13. High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: implications for celiac sprue. Piper JL; Gray GM; Khosla C Biochemistry; 2002 Jan; 41(1):386-93. PubMed ID: 11772038 [TBL] [Abstract][Full Text] [Related]
14. Unexpected role of surface transglutaminase type II in celiac disease. Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941 [TBL] [Abstract][Full Text] [Related]
15. Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A. Rauhavirta T; Qiao SW; Jiang Z; Myrsky E; Loponen J; Korponay-Szabó IR; Salovaara H; Garcia-Horsman JA; Venäläinen J; Männistö PT; Collighan R; Mongeot A; Griffin M; Mäki M; Kaukinen K; Lindfors K Clin Exp Immunol; 2011 Apr; 164(1):127-36. PubMed ID: 21235541 [TBL] [Abstract][Full Text] [Related]
16. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gianfrani C; Siciliano RA; Facchiano AM; Camarca A; Mazzeo MF; Costantini S; Salvati VM; Maurano F; Mazzarella G; Iaquinto G; Bergamo P; Rossi M Gastroenterology; 2007 Sep; 133(3):780-9. PubMed ID: 17678925 [TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity of antibodies against transglutaminase-deamidated gliadins in adult celiac disease. Falini ML; Elli L; Caramanico R; Bardella MT; Terrani C; Roncoroni L; Doneda L; Forlani F Dig Dis Sci; 2008 Oct; 53(10):2697-701. PubMed ID: 18306039 [TBL] [Abstract][Full Text] [Related]
18. Changes in Non-Deamidated versus Deamidated Epitope Targeting and Disease Prediction during the Antibody Response to Gliadin and Transglutaminase of Infants at Risk for Celiac Disease. Diós Á; Srinivasan B; Gyimesi J; Werkstetter K; Valenta R; Koletzko S; Korponay-Szabó IR Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269639 [TBL] [Abstract][Full Text] [Related]
19. Towards Celiac-safe foods: Decreasing the affinity of transglutaminase 2 for gliadin by addition of ascorbyl palmitate and ZnCl Engstrom N; Saenz-Méndez P; Scheers J; Scheers N Sci Rep; 2017 Mar; 7(1):77. PubMed ID: 28250436 [TBL] [Abstract][Full Text] [Related]